Quarterly report pursuant to Section 13 or 15(d)

Balance Sheets

v3.21.2
Balance Sheets - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Current assets    
Cash $ 29,800,632 $ 28,660,375
Total current assets 29,800,632 28,660,375
Acquired patents, net 14,421 16,227
Total assets 29,815,053 28,676,602
Current liabilities    
Accounts payable & accrued interest 627,577 710,971
Unreimbursed expenses 25,017 59,367
Advance from related party/shareholder 275,154
Total current liabilities 652,594 1,045,492
Total liabilities 652,594 1,045,492
Stockholders’ equity    
Common stock, $0.001 par value; 100,000,000 shares authorized; 12,920,253 and 12,703,541 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively 12,920 12,704
Additional paid-in capital 59,573,245 56,695,359
Accumulated deficit (30,423,706) (29,076,953)
Total stockholders’ equity 29,162,459 27,631,110
Total liabilities and stockholders’ equity $ 29,815,053 $ 28,676,602